IL-13 binding protein

Details for Australian Patent Application No. 2010251955 (hide)

Owner Glaxo Group Limited

Inventors Ashman, Claire; Ellis, Jonathan Henry; Hamblin, Paul Andrew; Lewis, Alan Peter; Orecchia, Martin Anibal

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2010251955

PCT Pub. Number WO2010/136481

Priority 61/288,930 22.12.09 US; 61/181,833 28.05.09 US

Filing date 26 May 2010

Wipo publication date 2 December 2010

International Classifications

C07K 16/24 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

C07K 16/46 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - Hybrid immunoglobulins

Event Publications

22 December 2011 PCT application entered the National Phase

  PCT publication WO2010/136481 Priority application(s): WO2010/136481

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010251961-Albumin-amyloid peptide conjugates and uses thereof

2010251950-Extraneous agents testing